CD8A and neoplasm: Anti-CD8 immuno-PET has proven to be a sensitive tool for detecting changes in systemic and tumor-infiltrating CD8 T-cell expression, while immuno-PET imaging of inducible T-cell costimulators (ICOS), enables the sensitive and specific detection of activated T cells (Xiao et al. 2020).